FIELD: medicine.
SUBSTANCE: claimed is human tumor cell and based on it vaccine.
EFFECT: invention can be used for therapeutic treatment of tumor diseases.
26 cl, 3 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF IMMUNOTHERAPY | 2014 |
|
RU2680010C2 |
LINE OF CELLS OF HUMAN MELANOMA KG, SECRETING RECOMBINANT GRANULOCYTIC MACROFAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2362805C1 |
HUMAN MELANOMA CELL LINE ILG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395574C1 |
HUMAN MELANOMA CELL LINE 26G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395571C1 |
HUMAN MELANOMA CELL LINE IG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395572C1 |
HUMAN MELANOMA CELL LINE 31G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395573C1 |
HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
COMPOSITIONS AND METHODS OF IMMUNOTHERAPY | 2014 |
|
RU2798348C2 |
MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES | 2007 |
|
RU2459631C2 |
Authors
Dates
2009-05-10—Published
2004-04-20—Filed